Yun Chun Li
Chairman chez WALVAX BIOTECHNOLOGY CO., LTD.
Fortune : 122 M $ au 29/02/2024
Profil
Actuellement, Yun Chun Li est président de Walvax Biotechnology Co., Ltd. Il siège également au conseil d'administration de Shanghai Zerun Biotech Co, Ltd, Genor Biopharma Co, Ltd et Jiangsu Convac Biotechnology Co, Ltd.
Détentions connues dans des sociétés publiques
Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
---|---|---|---|---|
30/09/2023 | 27 150 181 ( 1,74% ) | 69 M $ | 29/02/2024 | |
30/09/2023 | 20 362 636 ( 43,09% ) | 52 M $ | 29/02/2024 |
Postes actifs de Yun Chun Li
Sociétés | Poste | Début |
---|---|---|
WALVAX BIOTECHNOLOGY CO., LTD. | Chairman | 23/06/2009 |
Jiangsu Convac Biotechnology Co., Ltd.
Jiangsu Convac Biotechnology Co., Ltd. BiotechnologyHealth Technology Jiangsu Convac Biotechnology Co., Ltd. engages in the research and development, production, and sale of biological products. It offers new vaccines, genetic modified drugs and in vitro diagnostic reagents. The company was founded on October 13, 2011 and is headquartered in Taizhou, China. | Director/Board Member | - |
Genor Biopharma Co., Ltd.
Genor Biopharma Co., Ltd. BiotechnologyHealth Technology Genor Biopharma Co., Ltd. engages in the manufacture and development of antibodies and related biological products. Its business scope includes research and development of monoclonal antibodies and biological products; research and development of instruments, equipment and reagents related to monoclonal antibodies and biological products; and wholesale, import and export of instruments, mechanical equipment, pharmaceutical equipment, and pharmaceutical intermediates. The company was founded on December 4, 2007 and is headquartered in Shanghai, China. | Director/Board Member | - |
Shanghai Zerun Biotechnology Co., Ltd.
Shanghai Zerun Biotechnology Co., Ltd. BiotechnologyHealth Technology Shanghai Zerun Biotechnology Co., Ltd. engages in the development, commercialization, and industrialization of new recombinant human vaccine products. It develops recombinant vaccines such as preventive cervical cancer vaccines, and recombinant enterovirus 71 virus-like particle and therapeutic vaccines. The company was founded on May 7, 2003 and is headquartered in Shanghai, China. | Director/Board Member | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 4 |
---|---|
Walvax Biotechnology Co., Ltd. | |
Shanghai Zerun Biotechnology Co., Ltd.
Shanghai Zerun Biotechnology Co., Ltd. BiotechnologyHealth Technology Shanghai Zerun Biotechnology Co., Ltd. engages in the development, commercialization, and industrialization of new recombinant human vaccine products. It develops recombinant vaccines such as preventive cervical cancer vaccines, and recombinant enterovirus 71 virus-like particle and therapeutic vaccines. The company was founded on May 7, 2003 and is headquartered in Shanghai, China. | Health Technology |
Genor Biopharma Co., Ltd.
Genor Biopharma Co., Ltd. BiotechnologyHealth Technology Genor Biopharma Co., Ltd. engages in the manufacture and development of antibodies and related biological products. Its business scope includes research and development of monoclonal antibodies and biological products; research and development of instruments, equipment and reagents related to monoclonal antibodies and biological products; and wholesale, import and export of instruments, mechanical equipment, pharmaceutical equipment, and pharmaceutical intermediates. The company was founded on December 4, 2007 and is headquartered in Shanghai, China. | Health Technology |
Jiangsu Convac Biotechnology Co., Ltd.
Jiangsu Convac Biotechnology Co., Ltd. BiotechnologyHealth Technology Jiangsu Convac Biotechnology Co., Ltd. engages in the research and development, production, and sale of biological products. It offers new vaccines, genetic modified drugs and in vitro diagnostic reagents. The company was founded on October 13, 2011 and is headquartered in Taizhou, China. | Health Technology |